Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Lochhead P, Chan AT, Giovannucci E, Fuchs CS, Wu K, Nishihara R, O'Brien M, Ogino S.

Am J Gastroenterol. 2014 Aug;109(8):1205-14. doi: 10.1038/ajg.2014.153. Epub 2014 Jun 17. Review.

2.
3.

Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.

Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.

Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e.

PMID:
21836485
4.

Serrated pathway in colorectal carcinogenesis.

Yamane L, Scapulatempo-Neto C, Reis RM, Guimarães DP.

World J Gastroenterol. 2014 Mar 14;20(10):2634-40. doi: 10.3748/wjg.v20.i10.2634. Review.

5.

[Histopathological diagnosis and differential diagnosis of colorectal serrated polys: findings of a consensus conference of the working group "gastroenterological pathology of the German Society of Pathology"].

Baretton GB, Autschbach F, Baldus S, Bläker H, Faller G, Koch HK, Langner C, Lüttges J, Neid M, Schirmacher P, Tannapfel A, Vieth M, Aust DE.

Pathologe. 2011 Feb;32(1):76-82. doi: 10.1007/s00292-010-1365-3. Review. German.

PMID:
20924763
6.
7.

Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.

Tsai JH, Liau JY, Lin YL, Lin LI, Cheng YC, Cheng ML, Jeng YM.

Mod Pathol. 2014 Oct;27(10):1375-85. doi: 10.1038/modpathol.2014.35. Epub 2014 Mar 7.

8.

[Serrated precursor lesions].

Baretton GB, Aust DE.

Pathologe. 2011 Nov;32 Suppl 2:211-7. doi: 10.1007/s00292-011-1494-3. Review. German.

PMID:
21915664
9.

Serrated polyps and colorectal cancer: new pathway to malignancy.

Noffsinger AE.

Annu Rev Pathol. 2009;4:343-64. doi: 10.1146/annurev.pathol.4.110807.092317. Review.

PMID:
19400693
10.

Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.

Mesteri I, Bayer G, Meyer J, Capper D, Schoppmann SF, von Deimling A, Birner P.

Mod Pathol. 2014 Jan;27(1):135-44. doi: 10.1038/modpathol.2013.126. Epub 2013 Jul 26.

11.

Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.

Bossard C, Denis MG, Bézieau S, Bach-Ngohou K, Bourreille A, Laboisse CL, Mosnier JF.

Oncol Rep. 2007 Nov;18(5):1093-7.

PMID:
17914558
12.

Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions.

Tsai JH, Cheng CH, Chen CC, Lin YL, Lin LI, Chen ML, Liau JY.

Histopathology. 2016 May;68(6):810-8. doi: 10.1111/his.12814. Epub 2015 Oct 25.

PMID:
26496853
13.

The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.

Renaud F, Mariette C, Vincent A, Wacrenier A, Maunoury V, Leclerc J, Coppin L, Crépin M, Van Seuningen I, Leteurtre E, Buisine MP.

Int J Cancer. 2016 Mar 15;138(6):1472-81. doi: 10.1002/ijc.29891. Epub 2015 Oct 30.

14.

Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.

Messick CA, Church J, Casey G, Kalady MF.

Dis Colon Rectum. 2009 Sep;52(9):1535-41. doi: 10.1007/DCR.0b013e3181afbe05.

PMID:
19690479
15.

Role of the serrated pathway in colorectal cancer pathogenesis.

Leggett B, Whitehall V.

Gastroenterology. 2010 Jun;138(6):2088-100. doi: 10.1053/j.gastro.2009.12.066. Review.

PMID:
20420948
16.

MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.

Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y.

Int J Cancer. 2014 Dec 1;135(11):2507-15. doi: 10.1002/ijc.28920. Epub 2014 Apr 30.

17.

Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype.

Yamamoto E, Suzuki H, Yamano HO, Maruyama R, Nojima M, Kamimae S, Sawada T, Ashida M, Yoshikawa K, Kimura T, Takagi R, Harada T, Suzuki R, Sato A, Kai M, Sasaki Y, Tokino T, Sugai T, Imai K, Shinomura Y, Toyota M.

Am J Pathol. 2012 Nov;181(5):1847-61. doi: 10.1016/j.ajpath.2012.08.007. Epub 2012 Sep 17.

PMID:
22995252
18.

Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.

Yano Y, Konishi K, Yamochi T, Katagiri A, Nozawa H, Suzuki H, Toyota M, Kubota Y, Muramoto T, Kobayashi Y, Tojo M, Konda K, Makino R, Kaneko K, Yoshikawa N, Ota H, Imawari M.

Am J Gastroenterol. 2011 Jul;106(7):1351-8. doi: 10.1038/ajg.2011.76. Epub 2011 Mar 22.

PMID:
21427714
19.

KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.

Yamane LS, Scapulatempo-Neto C, Alvarenga L, Oliveira CZ, Berardinelli GN, Almodova E, Cunha TR, Fava G, Colaiacovo W, Melani A, Fregnani JH, Reis RM, Guimarães DP.

Oncol Rep. 2014 Oct;32(4):1419-26. doi: 10.3892/or.2014.3338. Epub 2014 Jul 18.

PMID:
25050586
20.

[Colorectal serrated lesions: current insight on their role in colorectal carcinogenesis].

Mäkinen M.

Duodecim. 2010;126(17):2002-11. Review. Finnish.

PMID:
21053517

Supplemental Content

Support Center